These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A Scalable Approach Reveals Functional Responses of iPSC Cardiomyocyte 3D Spheroids. Burnham MP; Harvey R; Sargeant R; Fertig N; Haddrick M SLAS Discov; 2021 Mar; 26(3):352-363. PubMed ID: 33283596 [TBL] [Abstract][Full Text] [Related]
25. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications. Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518 [TBL] [Abstract][Full Text] [Related]
26. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Xue T; Cho HC; Akar FG; Tsang SY; Jones SP; Marbán E; Tomaselli GF; Li RA Circulation; 2005 Jan; 111(1):11-20. PubMed ID: 15611367 [TBL] [Abstract][Full Text] [Related]
28. Video evaluation of the kinematics and dynamics of the beating cardiac syncytium: an alternative to the Langendorff method. Fassina L; Di Grazia A; Naro F; Monaco L; De Angelis MG; Magenes G Int J Artif Organs; 2011 Jul; 34(7):546-58. PubMed ID: 21786253 [TBL] [Abstract][Full Text] [Related]
29. Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes. Chun YW; Balikov DA; Feaster TK; Williams CH; Sheng CC; Lee JB; Boire TC; Neely MD; Bellan LM; Ess KC; Bowman AB; Sung HJ; Hong CC Biomaterials; 2015 Oct; 67():52-64. PubMed ID: 26204225 [TBL] [Abstract][Full Text] [Related]
32. Development and Characterization of a Scaffold-Free 3D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes. Beauchamp P; Moritz W; Kelm JM; Ullrich ND; Agarkova I; Anson BD; Suter TM; Zuppinger C Tissue Eng Part C Methods; 2015 Aug; 21(8):852-61. PubMed ID: 25654582 [TBL] [Abstract][Full Text] [Related]
33. A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation. Broughton KM; Li J; Sarmah E; Warren CM; Lin YH; Henze MP; Sanchez-Freire V; Solaro RJ; Russell B Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H107-17. PubMed ID: 27199119 [TBL] [Abstract][Full Text] [Related]
35. Arrhythmogenicity Test Based on a Human-Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocyte Layer. Slotvitsky M; Tsvelaya V; Frolova S; Dementyeva E; Agladze K Toxicol Sci; 2019 Mar; 168(1):70-77. PubMed ID: 30388253 [TBL] [Abstract][Full Text] [Related]
36. Comparison of Cardiomyocyte Differentiation Potential Between Type 1 Diabetic Donor- and Nondiabetic Donor-Derived Induced Pluripotent Stem Cells. Kikuchi C; Bienengraeber M; Canfield S; Koopmeiner A; Schäfer R; Bosnjak ZJ; Bai X Cell Transplant; 2015; 24(12):2491-504. PubMed ID: 25562386 [TBL] [Abstract][Full Text] [Related]
37. Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes After Acute Myocardial Infarction. Ong SG; Huber BC; Lee WH; Kodo K; Ebert AD; Ma Y; Nguyen PK; Diecke S; Chen WY; Wu JC Circulation; 2015 Aug; 132(8):762-771. PubMed ID: 26304668 [TBL] [Abstract][Full Text] [Related]
38. Microdevice Platform for Continuous Measurement of Contractility, Beating Rate, and Beating Rhythm of Human-Induced Pluripotent Stem Cell-Cardiomyocytes inside a Controlled Incubator Environment. Wang L; Dou W; Malhi M; Zhu M; Liu H; Plakhotnik J; Xu Z; Zhao Q; Chen J; Chen S; Hamilton R; Simmons CA; Maynes JT; Sun Y ACS Appl Mater Interfaces; 2018 Jun; 10(25):21173-21183. PubMed ID: 29874032 [TBL] [Abstract][Full Text] [Related]